Modulation of risk/reward decision making by dopaminergic transmission within the basolateral amygdala

Psychopharmacology (Berl). 2016 Jan;233(1):121-36. doi: 10.1007/s00213-015-4094-8. Epub 2015 Oct 3.

Abstract

Rationale: Dopamine (DA) transmission within cortico-limbic-striatal circuitry is integral in modulating decisions involving reward uncertainty. The basolateral amygdala (BLA) also plays a role in these processes, yet how DA transmission within this nucleus regulates cost/benefit decision making is unknown.

Objectives: We investigated the contribution of DA transmission within the BLA to risk/reward decision making assessed with a probabilistic discounting task.

Methods: Rats were well-trained to choose between a small/certain reward and a large/risky reward, with the probability of obtaining the larger reward decreasing (100-12.5 %) or increasing (12.5-100 %) over a session. We examined the effects of antagonizing BLA D1 (SCH 23390, 0.1-1 μg) or D2 (eticlopride, 0.1-1 μg) receptors, as well as intra-BLA infusions of agonists for D1 (SKF 81297, 0.1-1 μg) and D2 (quinpirole, 1-10 μg) receptors. We also assessed how DA receptor stimulation may induce differential effects related to baseline levels of risky choice.

Results: BLA D1 receptor antagonism reduced risky choice by decreasing reward sensitivity, whereas D2 antagonism did not affect overall choice patterns. Stimulation of BLA D1 receptors optimized decision making in a baseline-dependent manner: in risk-averse rats, infusions of a lower dose of SKF81297 increased risky choice when reward probabilities were high (50 %), whereas in risk-prone rats, this drug reduced risky choice when probabilities were low (12.5 %). Quinpirole reduced risky choice in risk-prone rats, enhancing lose-shift behavior.

Conclusions: These data highlight previously uncharacterized roles for BLA DA D1 and D2 receptors in biasing choice during risk/reward decision making through mediation of reward/negative feedback sensitivity.

Keywords: Basolateral amygdala; Decision making; Dopamine; Probabilistic discounting; Rat; Risk.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Basolateral Nuclear Complex / drug effects
  • Basolateral Nuclear Complex / metabolism*
  • Choice Behavior / drug effects
  • Choice Behavior / physiology
  • Decision Making / drug effects
  • Decision Making / physiology*
  • Dopamine / metabolism
  • Dopamine Agonists / pharmacology
  • Dopamine Antagonists / pharmacology
  • Male
  • Rats
  • Rats, Long-Evans
  • Receptors, Dopamine D1 / agonists
  • Receptors, Dopamine D1 / antagonists & inhibitors
  • Receptors, Dopamine D1 / metabolism*
  • Receptors, Dopamine D2 / agonists
  • Receptors, Dopamine D2 / metabolism*
  • Reward*
  • Risk-Taking*
  • Synaptic Transmission / drug effects
  • Synaptic Transmission / physiology

Substances

  • Dopamine Agonists
  • Dopamine Antagonists
  • Receptors, Dopamine D1
  • Receptors, Dopamine D2
  • Dopamine